loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 2350939 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    AbbVie Inc

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 BIMATOPROST (1)

    filter

    01 ABBVIE CORPORATION (1)

    filter

    01 SOLUTION (1)

    filter

    01 0.03%/W/V (1)

    filter

    01 Canada (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Bimatoprost

    PDF Supplier PDF
    URL Supplier Web Content
    SOLUTION
    0.03%/W/V
    LATISSE
    Canada
    2350939
    Prescription
    Abbvie Company Banner

    CPhI Japan

    Not Confirmed

    envelop Contact Supplier

    Looking for CTD TGA MCC DOSSIER APPLICATION 2350939

    Looking for CTD TGA MCC DOSSIER APPLICATION 2350939 1

    19

    AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is BIMATOPROST, with a corresponding application number 2350939 and regulatory information .

    proudly manufactured in the

    AbbVie Inc's LATISSE SOLUTION, medication with 0.03%/W/V of BIMATOPROST.

    Post Enquiry
    POST ENQUIRY